AdipoGen Life Sciences

anti-CTRP5 (globular domain) (human), pAb

CHF 190.00

In stock

AG-25A-0096-C100100 µgCHF 190.00

Figure 1: Western blot analysis using anti-CTRP5 (GD) (human), pAb (Prod. No. AG-25A-0096) at 1:4'000 dilution.
1: Human CTRP5 (His-tagged).
2: Human CTRP5 (GD) (His-tagged).
3: Mouse FTO (His-tagged) (negative control).
4: Human CTRP6 (His-tagged).

Specifications / Handling

More Information
Product Details
Synonyms	Complement C1q Tumor Necrosis Factor-related Protein 5; C1QTNF5
Product Type	Polyclonal Antibody
Properties
Source/Host	Rabbit
Immunogen/Antigen	Recombinant human CTRP5 (globular domain).
Application	ELISA: (direct and indirect: 1:2’000-1:5’000) Western Blot: (1:2’000-1:5’000 using ECL; suggested blocking and dilution buffer is PBST containing 0.05% Tween 20 and 5% skim milk; suggested incubation time is 1 hour at room temperature). Optimal conditions must be determined individually for each application. Note: Tested on recombinant proteins and/or target-protein transfected cell lines in ELISA, Western Blot and/or FACS.
Crossreactivity	Human
Specificity	Recognizes human CTRP5 (globular domain) and CTRP5 full-length protein. Detects a band of ~18kDa and ~30kDa by Western blot.
Purity Detail	Protein A-affinity purified.
Concentration	1mg/ml
Formulation	Liquid. 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives.
Isotype Negative Control	Rabbit IgG
Shipping and Handling
Shipping	BLUE ICE
Short Term Storage	+4°C
Long Term Storage	-20°C
Handling Advice	After opening, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles.
Use/Stability	Stable for at least 6 months after receipt when stored at -20°C.
Documents
MSDS	Download PDF
Product Specification Sheet
Datasheet	Download PDF

Product-specific References

Description

CTRP5 (C1qTNF-related protein 5; C1QTNF5) belongs to a highly conserved family of adiponectin paralogs. CTRP5 mediates activation of AMP-activated protein kinase (AMPK) in muscle and liver cells, thereby regulating glucose and lipid metabolism. Serum levels of CTRP5 are significantly higher in obese/diabetic animal models compared to normal controls. Furthermore, CTRP5 may be a putative biomarker for mitochondrial dysfunction. Defects in C1QTNF5 are a cause of late-onset retinal degeneration (LORD).

Product References

AMPK modulation ameliorates dominant disease phenotypes of CTRP5 variant in retinal degeneration: K.J. Miyagishima, et al.; Nature Comm. Biol. 4, 1360 (2021)

Call	+41 61 926 6040
Fax	+41 61 926 6049